
Cellebrite DI Ltd.: stock overview
Price
$11.53
November 13, 2026Market cap $2.9B
What Ploutos Investor adds for Cellebrite DI
Part of Ploutos Investor, €9.99 a month
- The full history: 7 fiscal years, from 2019
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
In short
Cellebrite DI had revenue of $476M in the fiscal year to December 31, 2025 and net income of $78M, a net margin of 16.5%. Revenue grew by 19.5% a year on average over the last 5 years. At $11.53 the shares trade at a P/E of 36.7, against a median of 18.2 over the last 3 fiscal years. It holds more cash than debt, by $276M. It pays no dividend.
From its SEC filings (latest fiscal year to December 31, 2025) and the price of November 13, 2026.
Its SEC filings- Market cap
- $2.9B
- 249M shares
- P/E
- 36.7
- Today36.7Median18.2
- Revenue, fiscal year
- $476M
- +19.5% a year over 5 years
- Net margin
- 16.5%
- above 81% of its industry
Worth knowing
What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.
3 fiscal years in figures
Each fiscal year's figures as the company filed them, and the share price at its end.
+21.0% a year over 2 years
Fiscal years in figures
CLBT's revenue, profit, cash flow and dividend with each year-end price, from 2019 to 2022, 4 more fiscal years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 5 fiscal years.
Key figures
The company's current figures in five groups. Each term is explained behind its ⓘ.
Valuation
- Market cap 3-year median: $4.5B
- $2.9B
- Enterprise value
- $2.6B
- P/E
- 36.7
- EV / EBIT
- 39.1
- EV / Revenue
- 5.5
- P/B 3-year median: 15.7
- 5.9
- FCF yield 3-year median: 3.6%
- 5.6%
- Earnings yield 3-year median: -5.0%
- 2.7%
Profitability
- Gross margin
- 84.2%
- Operating margin
- 14.0%
- Net margin 3-year median: -24.9%
- 16.5%
- ROIC
- 10.8%
- ROIC, 5-year average
- 12.1%
- ROE, fiscal year
- 16.2%
Growth
- Revenue, yearly change
- +18.6%
- EPS, yearly change
- –
- FCF, yearly change
- +29.7%
- Revenue, average a year
- +19.5%
The yearly change compares FY2025 with FY2024.
Balance sheet
- Cash
- $276M
- Total debt
- $23M
- Of which operating leases
- $23M
- Net cash
- $276M
- Net debt / EBITDA
- -3.5x
- Interest cover
- –
- Current ratio
- –
Balance sheet of December 31, 2025.
Returns to shareholders
- Dividend yield
- 0.00%
- Buybacks
- –
- Total returned
- 0.00%
- Shares, yearly change
- +4.2%
Against its industry
Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 73).
Gross margin
84.2%
Above 95% of the 293 companies in its industry, and 97% of all.
Operating margin
14.0%
Above 77% of the 462 companies in its industry, and 73% of all.
Net margin
16.5%
Above 81% of the 473 companies in its industry, and 78% of all.
ROE
16.2%
Above 76% of the 398 companies in its industry, and 78% of all.
ROA
8.3%
Above 80% of the 462 companies in its industry, and 84% of all.
Revenue growth
18.6%
Above 76% of the 461 companies in its industry, and 79% of all.
From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.
The company at the SEC
How it is registered and when its fiscal year ends.
- Name at the SEC
- Cellebrite DI Ltd.
- CIK
- 1854587
- Exchange
- NASDAQ
- Industry (SIC)
- 7372 · Services-Prepackaged Software
- Fiscal year ends
- December 31
- Latest annual report
- December 31, 2025
- Reporting currency
- USD
- Shares
- 249M
Other companies: Technology
The largest companies of the same sector, each with its own page.
- NVDANVIDIA+0,00%Compare with CLBT
- AAPLApple+0,00%Compare with CLBT
- MSFTMicrosoft+0,00%Compare with CLBT
- AVGOBroadcom+0,00%Compare with CLBT
- MUMicron Technology+0,00%Compare with CLBT
- AMDAdvanced Micro Devices+0,00%Compare with CLBT
- AMATApplied Materials+0,00%Compare with CLBT
- INTCIntel+0,00%Compare with CLBT
The full analysis
What do Cellebrite DI's filings show?
These are Cellebrite DI's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
What is CLBT's market cap?
Cellebrite DI Ltd.'s market cap is $2.9B, at a price of $11.53 on November 13, 2026 and 249M shares.
What is CLBT's P/E?
CLBT's P/E is 36.7, on earnings per share of $0.31 in the fiscal year to December 31, 2025. The median over the last 3 fiscal years was 18.2.
How much revenue does CLBT have?
Cellebrite DI had revenue of $476M in the fiscal year to December 31, 2025. Over the last 5 years it changed by +19.5% a year on average.
Does CLBT pay a dividend?
No. Cellebrite DI paid no regular dividend over the last 12 months.
Where do the figures come from?
From Cellebrite DI Ltd.'s SEC filings (its annual report on 20-F) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.